3Nielsen OW,Kirk V,Bay M,et al.Value of N-terminal pro brain natriuretic peptide in the elderly:data from the prospective copenhagen hospital heart failure study (CHHF)[J].Eur Heart Fail,2004,6:275-279.
4McCullough PA,Sandberg KR.Sorting out the evidence on natriuretic peptides[J].Rev Cardio Vasc Med,2003,4 (suppl 4):13.
5Yoshihiko S,Teruyo Y,Application of NT-proBNP and BNP measurements in care:a more discerning marker for the detection and evaluation of heart failure[J].the European Journal of heart Failure,2004:295-300.
6Executive summary of the guidelines on the diagnosis and treatment of acute heart failure:the Task Force on Acute Heart Failure of the European Society of Cardiology[J].Eur Heart J,2005,26:384-416.
7Bettencourt P,Ferreira A,Dias P,et al.Evaluation of brain natriuretic peptide in the diagnosis of heart failure[J].Cardiology,2000,93:19 -25.
8Hammerer-Lercher A,Neubauer E,Muller S,et al.Head-to-head comparison of N-terminal pro-brain natriuretic peptide,brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction[J].Clin Chim Acta,2001,310:193-197.
9Mc Cullough PA,Sandberg KR.Sorting out the evidence on natriuretic peptides[J].Rev Cardiovasc Med,2003,4 (suppl4):13 -19.
10Logeart D, Sandubray C, Beyne P, et al. Comparative value of Doppler echocardiography and B -type natriuretic peptide in the etiologic diagnosis of acute dyspnea [ J]. J Am Coil Cardiol, 2002, 40(10) :1794 - 1800.
